Pair Name | Artesunate, Fluorouracil | ||
Phytochemical Name | Artesunate (PubChem CID: 6917864 ) | ||
Anticancer drug Name | Fluorouracil (PubChem CID: 3385 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Drug Name | Fluorouracil |
Adverse Reactions | Application site erythema, application site pruritus. This was inferred hot nature anticancer drug. |
Recommendations | Cold: Pueraria thomsonii; Bupleurum scorzonerifolium; Pueraria thomsonii; Pueraria edulis |
Reference | Traditional Chinese medicine characteristics of chemotherapy regimens in advanced gastrointestinal malignant tumours[J]. Global Traditional Chinese Medicine,2023,16(8):1596-1599. DOI:10.3969/j.issn.1674-1749.2023.08.019. ref_link |
Pair Name | Artesunate, Fluorouracil | |||
Disease Info | [ICD-11: 2B91] | Colorectal cancer | Investigative | |
Biological Phenomena | Induction-->Cell senescence | |||
Gene Regulation | Down-regulation | Expression | CDKN1A | hsa1026 |
Down-regulation | Expression | CDKN2A | hsa1029 | |
Down-regulation | Phosphorylation | MAPK14 | hsa1432 | |
Down-regulation | Phosphorylation | MTOR | hsa2475 | |
Down-regulation | Phosphorylation | PRKAA1 | hsa5562 | |
Down-regulation | Phosphorylation | RELA | hsa5970 | |
Down-regulation | Expression | TP53 | hsa7157 | |
In Vitro Model | HCT 116 | Colon carcinoma | Homo sapiens (Human) | CVCL_0291 |
HIEC-6 | Healthy | Homo sapiens (Human) | CVCL_6C21 | |
In Vivo Model | HCT116 cells (1×10⁷) were subcutaneously inoculated into the left thigh dorsal region of nude mice, and tumor size was measured every 2 days for xenograft model establishment. | |||
Result | Our findings point to the crucial treatment effect of Arte on inflammation, intestinal cell senescence, and CRC cell proliferation and offer a new option for CRC treatment. |
No. | Title | Href |
---|---|---|
1 | Artesunate alleviates 5-fluorouracil-induced intestinal damage by suppressing cellular senescence and enhances its antitumor activity. Discov Oncol. 2023 Jul 27;14(1):139. doi: 10.1007/s12672-023-00747-7. | Click |